Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience.
Vijay S, Bansal N, Rao BK, Veeraraghavan B, Rodrigues C, Wattal C, Goyal JP, Tadepalli K, Mathur P, Venkateswaran R, Venkatasubramanian R, Khadanga S, Bhattacharya S, Mukherjee S, Baveja S, Sistla S, Panda S, Walia K. Vijay S, et al. Among authors: baveja s. Infect Drug Resist. 2021 May 24;14:1893-1903. doi: 10.2147/IDR.S299774. eCollection 2021. Infect Drug Resist. 2021. PMID: 34079300 Free PMC article.
Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive pneumococcal isolates collected in India.
Veeraraghavan B, Varghese R, Saigal K, Balasubramanian S, Bai PSP, Lal Y B, Neeravi A, Baskar P, Anandhan K, Kumar CPG, Jayaraman Y, Nag VL, Baveja S, J B, Joshi SA, Iyer R. Veeraraghavan B, et al. Among authors: baveja s. JAC Antimicrob Resist. 2021 Jun 1;3(2):dlab066. doi: 10.1093/jacamr/dlab066. eCollection 2021 Jun. JAC Antimicrob Resist. 2021. PMID: 34223128 Free PMC article.
Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019.
Katoch O, Katyal S, Srivastav S, Rodrigues C, Rupali P, Chakrabarti A, Ray P, Tak V, Biswal M, Nath R, Mukhopadhyay C, Bhattacharya S, Padmaja K, Deotale V, Venkatesh V, Wattal C, Ma T, Nag VL, Ray R, Behera B, Baveja S, Karuna T, Singh SK, Fomda B, Devi SK, Das P, Khandelwal N, Verma P, Gaind R, Bhattacharyya P, Kumar P, Srivastava A, Iravane J, Majumdar T, Sharma R, Sankara D, Kalwaje Eshwara V, Varma M, Nazir S, Tripathy S, Mishra S, Dey A, Thangavelu P, Kapoor L, Malhotra R, Walia K, Guleria R, Mathur P. Katoch O, et al. Among authors: baveja s. Am J Infect Control. 2022 Apr;50(4):390-395. doi: 10.1016/j.ajic.2021.09.019. Epub 2021 Sep 30. Am J Infect Control. 2022. PMID: 34600081
A self-reported survey on the implementation of infection prevention and control elements in Indian hospitals, part of a HAI surveillance network: Results from 23 hospitals conducting a standardized IPC assessment.
Katyal S, Srivastav S, Katoch O, Rodrigues C, Rupali P, Chakrabarti A, Ray P, Biswal M, Tak V, Nath R, Mukhopadhyay C, Bhattacharya S, Padmaja K, Deotale V, Venkatesh V, Wattal C, Ma T, Nag VL, Ray R, Behera B, Baveja S, Karuna T, Singh SK, Fomda B, Devi SK, Das P, Khandelwal N, Verma P, Thangavelu P, Nazir S, Eshwara VK, Varma M, Mishra TS, Das RR, Malhotra R, Walia K, Guleria R, Mathur P. Katyal S, et al. Among authors: baveja s. Am J Infect Control. 2023 Jan;51(1):29-34. doi: 10.1016/j.ajic.2022.04.014. Epub 2022 May 13. Am J Infect Control. 2023. PMID: 35577058
Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study.
Mathur P, Malpiedi P, Walia K, Srikantiah P, Gupta S, Lohiya A, Chakrabarti A, Ray P, Biswal M, Taneja N, Rupali P, Balaji V, Rodrigues C, Lakshmi Nag V, Tak V, Venkatesh V, Mukhopadhyay C, Deotale V, Padmaja K, Wattal C, Bhattacharya S, Karuna T, Behera B, Singh S, Nath R, Ray R, Baveja S, Fomda BA, Sulochana Devi K, Das P, Khandelwal N, Verma P, Bhattacharyya P, Gaind R, Kapoor L, Gupta N, Sharma A, VanderEnde D, Siromany V, Laserson K, Guleria R; Indian Healthcare Associated Infection Surveillance Network collaborators. Mathur P, et al. Among authors: baveja s. Lancet Glob Health. 2022 Sep;10(9):e1317-e1325. doi: 10.1016/S2214-109X(22)00274-1. Lancet Glob Health. 2022. PMID: 35961355 Free article.
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.
Veeraraghavan B, Bakthavatchalam YD, Manesh A, Lal B, Swaminathan S, Ansari A, Subbareddy K, Rangappa P, Choudhuri AH, Nagvekar V, Mehta Y, Appalaraju B, Baveja S, Baliga S, Shenoy S, Bhardwaj R, Kongre V, Dattatraya GS, Verma B, Mukherjee DN, Gupta S, Shanmugam P, Iravane J, Mishra SR, Barman P, Chopra S, Hariharan M, Surpam R, Pratap R, Turbadkar D, Taklikar S; Drug Discovery group, Wockhardt. Veeraraghavan B, et al. Among authors: baveja s. Indian J Med Microbiol. 2023 Jan-Feb;41:71-80. doi: 10.1016/j.ijmmb.2022.11.005. Epub 2022 Dec 9. Indian J Med Microbiol. 2023. PMID: 36509611 Review.
In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India.
Bakthavatchalam YD, Elangovan D, Jaganathan SV, Subburaju N, Shankar A, Manokaran Y, J S, Devi R, Baveja S, Devi S, S J, Bhattacharya S, S M R, Yesudhason B, Shetty V, Mutreja A, Manesh A, Varghese GM, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B. Bakthavatchalam YD, et al. Among authors: baveja s. Microbiol Spectr. 2023 Feb 27;11(2):e0492522. doi: 10.1128/spectrum.04925-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36847537 Free PMC article.
85 results